Commitments and Contingencies (Details) - USD ($) |
11 Months Ended | 12 Months Ended | ||
|---|---|---|---|---|
Dec. 31, 2021 |
Dec. 31, 2023 |
Dec. 31, 2022 |
Feb. 07, 2022 |
|
| Lessee, Lease, Description [Line Items] | ||||
| Purchase obligation | $ 42,800,000 | |||
| Purchase obligation, to be paid within one year | 36,000,000 | |||
| Purchase obligation, to be paid, over one to four years | 6,800,000 | |||
| Lease term | 10 years | |||
| Letter of credit outstanding | $ 700,000 | |||
| Collaborative Arrangement, Transaction with Party to Collaborative Arrangement | ||||
| Lessee, Lease, Description [Line Items] | ||||
| Maximum aggregate development and regulatory milestone payments | 0 | |||
| Research and development expense | $ 1,700,000 | 2,200,000 | ||
| Collaborative Arrangement, Transaction with Party to Collaborative Arrangement | Orexia | ||||
| Lessee, Lease, Description [Line Items] | ||||
| Maximum aggregate development milestone payments | 43,700,000 | |||
| Maximum aggregate commercial milestone payments | $ 42,000,000 | |||
| Forecast | ||||
| Lessee, Lease, Description [Line Items] | ||||
| Rent expense | $ 1,600,000 | |||
| Rent expense, year 10 | $ 1,900,000 | |||